面罩采样检测呼出结核分枝杆菌及亚临床结核病
该研究在南非比勒陀利亚开展两项前瞻性观察性研究:24例经微生物学确诊的肺结核患者完成24小时内8次1小时面罩采样及同期痰采样,面罩样本Mtb检出率86%远高于痰标本21%;另在非正式定居点对20名有症状者进行主动筛查,8例确诊肺结核,其中6例仅面罩阳性。
要点
- 面罩采样对呼出Mtb的检出率显著高于同期痰标本。
- 面罩采样可早于痰检和影像学发现亚临床结核病。
- 面罩采样为无创、高效,适用于难以触达人群的筛查。
核心结论
- 面罩采样是一种高效、无创的呼出Mtb检测方法,较痰标本更一致且更早提示活动性感染。
研究设计与样本
- 纵向研究纳入南非三家医院24例微生物学确诊的肺结核患者,24小时内完成8次1小时面罩采样及同期痰采样,以定量PCR检测Mtb。
- 主动筛查试点研究纳入比勒陀利亚附近非正式定居点20名有结核症状者,采集痰和面罩样本用Xpert MTB/RIF Ultra检测,对痰阴性面罩阳性者随访20周。
主要发现
- 24小时纵向研究中,192份面罩样本中166份(86%)检出Mtb,184份可评估痰样本中38份(21%)检出Mtb。
- 呼出Mtb输出量无昼夜规律,且与咳嗽频率、痰菌含量或胸部影像学病变严重程度无关。
- 主动筛查试点中,20名有症状参与者里8例前瞻性诊断为肺结核,其中6例筛查时仅面罩阳性。
- 6例仅面罩阳性者中4例(3例HIV阳性)胸片正常,但PET-CT显示治疗有效的早期结核兼容病灶,6周后痰Xpert阳性。
临床怎么用
- 面罩采样可作为肺结核诊断和主动筛查的无创检测手段,尤其在资源有限或难以触达的社区。
- 对痰检阴性但面罩阳性的个体,应结合影像学和随访进一步验证结核病诊断。
局限性
- 纵向研究纳入24例患者,样本量有限,且多数合并HIV感染。
- 主动筛查试点样本量小,结果需在更大规模人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis remains a global health challenge, with early diagnosis key to its reduction. Face-mask sampling detects exhaled Mycobacterium tuberculosis. We aimed to investigate bacillary output from patients with pulmonary tuberculosis and to assess the potential of face-mask sampling as a diagnostic method in active case-finding. METHODS: We did a 24-h longitudinal study in patients from three hospitals in Pretoria, South Africa, with microbiologically confirmed pulmonary tuberculosis. Patients underwent 1 h of face-mask sampling eight times over a 24-h period, with contemporaneous sputum sampling. M tuberculosis was detected by quantitative PCR. We also did an active case-finding pilot study in inhabitants of an informal settlement near Pretoria. We enrolled individuals with symptoms of tuberculosis on the WHO screening questionnaire. Participants provided sputum and face-mask samples that were tested with the molecular assay Xpert MTB/RIF Ultra. Sputum-negative and face-mask-positive individuals were followed up prospectively for 20 weeks by bronchoscopy, PET-CT, and further sputum analysis to validate the diagnosis. FINDINGS: Between Sept 22, 2015, and Dec 3, 2015, 78 patients with pulmonary tuberculosis were screened for the longitudinal study, of whom 24 completed the study (20 had HIV co-infection). M tuberculosis was detected in 166 (86%) of 192 face-mask samples and 38 (21%) of 184 assessable sputum samples obtained over a 24-h period. Exhaled M tuberculosis output showed no diurnal pattern and did not associate with cough frequency, sputum bacillary content, or chest radiographic disease severity. On May 16, 2018, 45 individuals were screened for the prospective active case-finding pilot study, of whom 20 had tuberculosis symptoms and were willing to take part. Eight participants were diagnosed prospectively with pulmonary tuberculosis, of whom six were exclusively face-mask positive at screening. Four of these participants (three of whom were HIV-positive) had normal findings on chest radiography but had treatment-responsive early tuberculosis-compatible lesions on PET-CT scans, with Xpert-positive sputum samples after 6 weeks. INTERPRETATION: Face-mask sampling offers a highly efficient and non-invasive method for detecting exhaled M tuberculosis, informing the presence of active infection both with greater consistency and at an earlier disease stage than with sputum samples. The approach shows potential for diagnosis and screening, particularly in difficult-to-reach communities. FUNDING: Wellcome Trust, CARA (Council for At-Risk Academics), University of Leicester, the UK Medical Research Council, and the National Institute for Health Research. VIDEO ABSTRACT.
引用
- Williams CM, Abdulwhhab M, Birring SS, et al. Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies. Lancet Infect Dis. 2020. PMID: 32085847. doi:10.1016/S1473-3099(19)30707-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。